| This article has been cited by |
| 1 | An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy | |
| Jacob Kaiserman,Bethany A. O’Hara,Sheila A. Haley,Walter J. Atwood |
| International Journal of Molecular Sciences.2023;24(10)8580 |
| [DOI] |
|
| 2 | Pharmacokinetic Profile of Oral Administration of Mefloquine to Clinically Normal Cats: A Preliminary In-Vivo Study of a Potential Treatment for Feline Infectious Peritonitis (FIP) | |
| Jane Yu,Benjamin Kimble,Jacqueline M. Norris,Merran Govendir |
| Animals.2020;10(6)1000 |
| [DOI] |
|
| 3 | Progressive multifocal leukoencephalopathy successfully treated with mefloquine and literature review | |
| Sungjoon Yoon,Yongmoo Kim,Seon-Jae Ahn,Kon Chu |
| encephalitis.2021;1(4)111 |
| [DOI] |
|
| 4 | Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report | |
| Beyza Cifci,Yesim Yildiz,Emine Altin,Hamid Habibi,Belgin Kocer,Murat Dizbay |
| Journal of NeuroVirology.2023;29(1)111 |
| [DOI] |
|
| 5 | The Use of Antimalarial Drugs against Viral Infection | |
| Sarah D’Alessandro,Diletta Scaccabarozzi,Lucia Signorini,Federica Perego,Denise P. Ilboudo,Pasquale Ferrante,Serena Delbue |
| Microorganisms.2020;8(1)85 |
| [DOI] |
|
| 6 | Progressive multifocal leukoencephalopathy in idiopathic CD4
+
lymphocytopenia: A case report and review of literature | |
| Divya Aggarwal,Jesty Pullatu Tom,Debajyoti Chatterjee,Manoj Goyal |
| Neuropathology.2019;39(6)467 |
| [DOI] |
|
| 7 | Progressive multifocal leukoencephalopathy in idiopathic CD4+ lymphocytopenia | |
| Rajeswari Aghoram,Sunil K. Narayan |
| Journal of NeuroVirology.2018;24(4)526 |
| [DOI] |
|
| 8 | Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab | |
| Daniele Focosi,Marco Tuccori,Fabrizio Maggi |
| Reviews in Medical Virology.2019;29(6)526 |
| [DOI] |
|
| 9 | Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions | |
| Charles L Bennett,Daniele Focosi,Mariana P Socal,Julia C Bian,Chadi Nabhan,William J Hrushesky,Andrew C Bennett,Martin W Schoen,Joseph R Berger,James O Armitage |
| The Lancet Haematology.2021;8(8)e593 |
| [DOI] |
|
| 10 | A human T-lymphotropic virus-1 carrier who developed progressive multifocal leukoencephalopathy following immunotherapy for sarcoidosis: a case report | |
| Takashi Nagahori,Wataru Shiraishi,Masafumi Nishikawa,Ayano Matsuyoshi,Takenori Ogura,Yui Yamada,Kenta Takahashi,Tadaki Suzuki,Kazuo Nakamichi,Tetsuya Hashimoto,Taketo Hatano |
| BMC Neurology.2023;23(1)e593 |
| [DOI] |
|
